Calcium channels and their involvement in cardiovascular disease

Biochemical Pharmacology

Volumn 43, Issue 1, 1992, Pages 39-46

  Nayler, Winifred G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDRO 2 ISOPROPYL 4 METHYL 2 [2 [4 [4 [2 (3,4,5 TRIMETHOXYPHENYL)ETHYL]PIPERAZINYL]BUTOXY]PHENYL] 2H 1,4 BENZOTHIAZIN 3 ONE; BENZOTHIAZEPINE DERIVATIVE; CALCISEPTINE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; NIFEDIPINE; PHENYLALKYLAMINE; PIMOZIDE; POLYPEPTIDE; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; VERAPAMIL;

ATHEROGENESIS; BINDING SITE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; HEART INFARCTION; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

BINDING SITES; BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CARDIOVASCULAR DISEASES; DRUG DESIGN; HUMAN; SUPPORT, NON-U.S. GOV'T;

EID: 0026536766     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(92)90658-6     Document Type: Article

References (57)

1. Classes of calcium channels in vertebrate cells
2. Multiple calcium channels and neuronal function
3. Blocking and isolation of a calcium channel from neurons in mammals and cephalopods utilizing a toxin fraction (FTX) from funnel web spider poison
4. Funnel-web spider venom and a toxic fraction block calcium current expressed from rat brain mRNA in Xenopus oocytes
5. Calciseptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel
6. 1 subunit of the dihydropyridine-sensitive calcium channel isolated from rat brain and rat aorta
7. “Up” and “down” regulation of the calcium antagonist binding sites
8. Molecular properties of dihydropyridine-sensitive calcium channels
9. Purified dihydropyridine-binding site from skeletal muscle T-tubules is a functional calcium channel
10. Reconstitution of the voltage-sensitive calcium channel purified from skeletal muscle transverse tubules
11. Evidence for physical association between junctional sarcoplasmic reticulum ryanodine receptor and junctional transverse tubular dihydropyridine receptor
12. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling
13. cDNA cloning of a dihydropyridine sensitive calcium channel from rat aorta
14. Existence of distinct sodium channel messenger RNA's in rat brain
15. Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel
16. 2 subsequently of the DHP-sensitive calcium channel
17. Molecular properties of calcium channels
18. Amlodipine, a new dihydropyridine calcium channel blocker with slow onset and duration of action
19. 3H]Amlodipine binding to rat cardiac membranes
20. Calcium antagonism and calcium entry blockade
21. 2 receptors anf voltage-sensitive calcium channels
22. 2+ antagonist effects
23. The cellular mechanism of action of nimodipine (Baye9736) a new calcium antagonist
24. Pharmacological basis for the use of nimodipine in central nervous system disorders
25. Excitation-contraction coupling and the ultrastructure of smooth muscle
26. Sympathetic neuroeffector transmission in arteries and arterioles
27. Calcium currents are altered in the vascular muscle cell membranes of spontaneously hypertensive rats
28. Effects of a chronic treatment of nisoldipine, a calcium antagonistic dihydropyridine, on arteries of spontaneously hypertensive rats
29. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension
30. 2+ signalling after α adrenoceptor activation in vascular hypertrophy
31. The stunned myocardium: prolonged, postischemic ventricular dysfunction
32. The hibernating myocardium
33. Kinetics of calcium accumulation in acute myocardial ischemic injury
34. The cell biology of acute myocardial ischemia
35. Fundamental mechanisms of action of calcium antagonists in myocardial ischemia
36. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish verapamil infarction trial 11)
37. The effect of diltiazem on mortality and reinfarction after myocardial infarction
38. The oxygen free-radical system: potential mediator of myocardial injury
39. Mechanism of myocardial “stunning”
40. Single channel recordings from human cardiac sarcoplasmic reticulum
41. 3H]Verapamil binding to rat cardiac sarcolemmal membrane fragments: an effect of ischaemia
42. Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage
43. Cytosolic free calcium during focal cerebral ischemia and the effects of nimodipine on calcium and histological damage
44. Second generation calcium antagonists and the ischemic myocardium
45. Calcium antagonists and the management of cerebral ischaemia
46. Calcium antagonists and atherosclerosis
47. Atherogenesis calcium and calcium antagonists
48. History of calcium antagonists
49. Calcium dependency of aortic smooth muscle cell migration induced by 12-l-hydroxy-5,8,10,14-eicosatetraenoic acid
50. The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation
51. Antiatherosclerotic effects of verapamil in primary culture of human aortic intimal cells
52. Inhibition of cholesteryl ester deposition in macrophages by calcium entry blockers: an effect dissociable from calcium entry blockade
53. Antiperoxidant effects of dihydropyridine calcium antagonists
54. Lipid peroxidation of phosphatidylcholine liposomes depressed by the calcium channel blockers nifedipine and verapamil and by the antiarrhythmic-antihypoxic drug stobadine
55. Interaction between endothelin-1 and endothelin-derived relaxing factor in human arteries and veins